Test Menu Category: Fluorescence in-situ Hybridization

Background

FISH, a molecular cytogenetic technique, enables the analysis of disease specific abnormalities. It is offered for the detection of cryptic rearrangements, microdeletion syndromes, aneuploidy, and marker chromosome identification.

This branch of cytogenetic analysis is more specific than standard karyotype analysis, enabling analysis of disease-specific abnormalities. Using results from previous testing, specific gene locations can be selected for investigation. FISH is offered for the detection of translocations, microdeletion syndromes, aneuploidy and marker chromosome identification.


Fluorescence in-situ Hybridization Tests

Abc-Z FISH, interphase

Acute Lymphoblastic Leukemia (ALL) Adult Panel by FISH

ALK 2p23 rearrangement by FISH

AML1(RUNX1)/ETO(RUNXT1) t(8;21) by FISH

Angelman Syndrome deletion 15q11-13 by FISH*

API2/MALT1 t(11;18) by FISH

ATM/CEP11 deletion 11q22.3 by FISH

BCL6 3q27 Rearrangement by FISH

BCR/ABL1 t(9;22) by FISH

Bladder Cancer Panel +3,+7,+17,9p21- by FISH

Burkitt/“Double Hit” Large B-cell Lymphoma Panel by FISH

C MYC 8q24 Rearrangement by FISH

CBFB t(16;16), inv(16) by FISH

CEP 7 -7/7q31- by FISH

Chronic Lymphocytic Leukemia (CLL) Panel by FISH

Cri-du-Chat / SOTOS Syndrome by FISH*

Deletion 13q14.3 by FISH

Deletion 20q12 by FISH

deletion 7q22 by FISH

DiGeorge/Velo-Cardio-Facial Syndrome deletion 22q11.2 by FISH*

1 2 3